Prasugrel
Product Images NDC 67877-604

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Prasugrel (NDC 67877-604). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ascend Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Prasugrel Tablets 01)

A line graph comparing the percentage of non-CABG-related TIMI major or minor bleeding events over 450 days for Prasugrel and Clopidogrel. The y-axis represents the percentage of bleeding events, and the x-axis shows days from randomization. Prasugrel shows a higher cumulative bleeding event percentage than Clopidogrel throughout the study period. A small inset graph shows early event rates over 7 days. Numbers at risk for each drug are displayed below the x-axis.*

FDA Label Image

Prasugrel Structure (Prasugrel Tablets 02)

Chemical structure of Prasugrel hydrochloride, showing its bicyclic core including a thiophene ring fused to a benzene ring, with additional functional groups such as a fluorophenyl, acetoxy, and cyclopropyl moieties attached.*

FDA Label Image

Figure 2 (Prasugrel Tablets 03)

A line graph depicting the inhibition of platelet aggregation (%) over time (hours) after administration of 20 µM ADP. The y-axis shows inhibition percentage from -20 to 100%, and the x-axis shows time from 0 to 24 hours. Data points include mean values with standard deviation bars.*

FDA Label Image

Figure 3a (Prasugrel Tablets 04)

A line graph comparing cardiovascular death, nonfatal myocardial infarction, or nonfatal stroke percentages over 450 days from randomization for Prasugrel versus Clopidogrel in UA/NSTEMI patients. The chart includes p-values indicating statistical significance and features an inset graph showing a similar comparison with smaller y-axis values.*

FDA Label Image

Figure 3b (Prasugrel Tablets 05)

A line graph comparing the cumulative percentage of cardiovascular death, nonfatal myocardial infarction, or nonfatal stroke over days from randomization up to around 450 days between Prasugrel and Clopidogrel in patients with STEMI. Prasugrel shows a lower cumulative event rate over time compared to Clopidogrel. An inset graph zooms in on the first 7 days with a similar comparison and p-values indicated on both graphs.*

FDA Label Image

Figure 4 (Prasugrel Tablets 06)

A forest plot chart comparing percent events and hazard ratios between Prasugrel and Clopidogrel across various baseline characteristics such as age, gender, body weight, region, diabetes, metabolic syndrome, previous medical history, and time from symptom onset. The chart displays sample sizes, event percentages, and hazard ratio confidence intervals for each subgroup.*

FDA Label Image

Figure 5 (Prasugrel Tablets 07)

A forest plot displaying baseline characteristics and percent events comparing Prasugrel and Clopidogrel. The chart shows hazard ratios and confidence intervals for variables such as age, gender, body weight, region, diabetes status, metabolic syndrome, previous medical conditions, time from symptom onset, stent type, and GP IIb/IIIa inhibitor use, with a central line indicating equivalence between Prasugrel and Clopidogrel outcomes.*

FDA Label Image

Prasugrel-10 mg (Prasugrel Tablets 10mg V02)

Label for Prasugrel Tablets 10 mg by Ascend Laboratories, LLC, containing 30 tablets. The label states prausgrel hydrochloride equivalent to 10 mg prasugrel per tablet, storage instructions, and dispensing guidance. It includes manufacturer information for Windlas Healthcare (P) Ltd., barcode, and space for batch, expiration, and QR code details.*

FDA Label Image

Prasugrel-5 mg (Prasugrel Tablets 5mg V02)

Label for Prasugrel 5 mg tablets by Ascend Laboratories, LLC. The label indicates each tablet contains prasugrel hydrochloride equivalent to 5 mg prasugrel and provides storage instructions. The package contains 30 tablets and includes manufacturer and distributor information, a barcode, and caution about the inner seal. The label also refers to accompanying medication guide and dosage literature.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.